A new study suggests that drinking coffee may prolong the survival time and less cancer progression in patients diagnosed with colorectal (or colon) cancer.
Compared to the people who drank none, those who drank one cup a day had an 11 percent increased chance of survival as well as a five percent increase rate of living without their disease getting worse.
The study claimed that the more coffee that they drank, the better. Patients who drank four or more cups a day had a 36 percent chance of overall survival and a 22 percent rate of progression-free living.
Researchers monitored about 1,171 patients diagnosed with advanced or metastatic colon or rectal cancer who are no longer candidates for surgery. The patients accomplished their lifestyle and diet questionnaires, including data about their coffee consumption, at the start of the study.
Published in JAMA Oncology, a medical journal published by the American Medical Association, controlled for race, smoking, alcohol intake, drug use, diabetes, and the addition of other ingredients like milk, non-dairy creamers, or sweeteners to the coffee.
It showed that regardless of the coffee being decaffeinated or regular, the statistics mentioned in their living conditions still remain.
According to the study’s co-lead author, Christopher Mackintosh, a fourth-year medical student at the Mayo Clinic Alix School of Medicine, drinking coffee is neither a cure nor treatment for cancer.
He emphasized that patients should begin drinking coffee in efforts of treating or preventing cancer.